Cerebral magnetic resonance spectroscopy in patients with hepatic encephalopathy: Analysis before and after liver transplantation;Espectroscopia cerebral em candidatos a transplante hepático

Revista da Associacao Medica Brasileira

Volumn 55, Issue 1, 2009, Pages 35-39

  Schulz, Gustavo Justo ^a   Coelho, Julio Cézar Uili ^a   Matias, Jorge Eduardo Fouto ^a   Campos, Antônio Carlos Ligocki ^a   Schulz, Danielle Duck ^a   Bertoldi, Guilherme Augusto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Brain disease; Liver transplantation; Magnetic resonance spectroscopy; Spectrum analysis

Indexed keywords

ASPARTIC ACID; CHOLINE; CREATINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INOSITOL; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ARTICLE; BIOSYNTHESIS; BRAIN; CASE CONTROL STUDY; ENERGY METABOLISM; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHOLINE; CREATINE; ENERGY METABOLISM; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INOSITOL; LIVER TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 67649962312     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. th ed. New York: McGraw-Hill; 1997. p. 33-38.
2. Bárány M, Langer BG, Glick RP, Venkatasubramanian PN, Wilbur ACSpigos DG. In vivo H-l spectroscopy in humans at 1,5T. Radiology. 1988;167:839-44.
3. Bertolucci RG, Brucki SMD, Campacci SR Juliano Y. O mini-exame doestado mental em uma população geral. Arq Neuropsiquiatr. 1994;52:1-7.
4. Brucki SMD, Malheiros SMF, Okamoto IH, Bertolucci PHF. Dados normativos para o teste de fluência verbal categoria animais em nosso meio. Arq Neuropsiquiatr. 1997;55:56-61.
5. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189-98.
6. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Aandus T, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology. 1997;25:48-54.
7. Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol. 1988;83:8-11.
8. Kurhanewicz J, Bok R, Nelson SJ, Vigneron DB. Current and potential applications of clinical I3C MR Spectroscopy. J Nucl Med. 2008; 34l-5.
9. Hockerstedt K, Kajaste S, Isoniemi H, Muuronen A, Raininko R,Seppalainen AM, et al. Tests of encephalopathy before and after livertransplantation. Transplant Proc. 1992;22:1576-8.
10. Kreis R Farrow N, Ross BD. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet. 1990;336:635-6.
11. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-l MR spectroscopy. Radiology. 1992;182:19-27.
12. Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D. MRfindings in chronic hepatic encephalopathy depend on portossystemicshunt: results of a controlled prospective clinical investigation. J Hepatol. 1997;27:l2l-6.
13. Krieger D, Krieger S. Markers of reversible hepatic encephalopathy. Neurology. 1997;49:1187-8.
14. Laubenberger J, Häussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton Magnetic Resonance spectroscopy of the brain in symptomatic an asymptomatic patients with liver cirrhosis. Gastroenterology. 1997;112:1610-6.
15. Lezak MD. Neuropsychological assessment. 3 ed. New York: Oxford; 1997.
16. Luyten PR, Den Hollander JA. Observation of metabolites in the human brain by MR spectroscopy. Radiology; 1986;161:795-8.
17. Moll J, Oliveira-Souza R Moll FT, Bramati IE, Andreiuolo PA. The cerebral correlates of set-shifting. Arq Neuropsiquiatr; 2002;60:900-5.
18. Näegele T, Grodd W, Viebahn R Seeger U, Klose U, Seitz D, et al. MR imaging and 'H spectroscopy of brain metabolics in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology. 2000;216:683-91
19. Neuberger J, McMaster P. Liver transplantation: indications. In: Blungart LH, editor Surgery of the liver and billiary tract. Philadelphia: WB Saunders; 1994. p.1801-10.
20. Oppong KNW, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotic patients pre e post-liver transplantation: a psychometric and analyzed EEG study. Hepatology. 1997;26:870-6.
21. th Annual Meeting; 2007. Abstract 768.
22. Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol. 2008;26:1936-59.
23. Rehnstróm S, Simert G, Hanssons JA, Johson G, Vang J. Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol. 1977;12:305-11.
24. Romero-Gómez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-23.
25. Rosa H. Encefalopatia Hepatica. In: Kalil NA, Coelho J, Strauss E. Figado e vias biliares: clinica e cirurgia. Rio de Janeiro: Revinter; 2001 p.102-9.
26. Ross BD, Kreis R, Ernst T. Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol. 1993;14:128-40.
27. Ross BD, Jacbson S, Villamil F, Korula J, Kreis R Ernst T, et al. Subclinical Hepatic Encephalopaty: proton MR spectroscopic abnormalities. Radiology. 1994;193:457-63.
28. Miese F, Kircheis G, Wittsack HJ, Wenserki F, Hemker J, Mödder U: et al. H-MR spectroscopy magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol. 2006;27:1019-26.
29. Weissenborn K, Ahl B, Fischer-Wasels D, Van den Hoff J, Hecker H: Burchert W, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut. 2007;56:1736-42.
30. Thomas MA, Huda A, Guze B, Curran J, Bugbee M, Fairkanks L, et al. Cerebral H MR spectroscopy and neuropsychologic status of patientas with hepatic encephalopathy. AJR Am J Roentgenol. 1998;171:1123-30.
31. Wechsler D. Wais-R Manual: the psychological corporation Orlando: Harcout Brave Jovanovich, Inc.; 1981.
32. Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD. Changes in brain size in hepatic encephalopathy: a coregistered MR study. Metab Brain Dis. 2005;19:431-5.